Company Filing History:
Years Active: 2012-2014
Title: Erin Keaney: Innovator in Vps34 Inhibition
Introduction
Erin Keaney is a notable inventor based in Belmont, MA (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit Vps34, a protein associated with various diseases.
Latest Patents
Erin Keaney holds 3 patents related to her innovative work. Her latest patents focus on bi-heteroaryl compounds as Vps34 inhibitors. These inventions include novel methods for treating diseases characterized by hyperactivity of Vps34. The compounds, particularly those of Formula I, are designed to serve as Vps34 inhibitors and are accompanied by pharmaceutical compositions that include these compounds and their pharmaceutically acceptable salts.
Career Highlights
Erin Keaney is currently employed at Novartis AG, where she continues to advance her research and development efforts. Her work has the potential to impact the treatment of hyperproliferative diseases significantly.
Collaborations
Throughout her career, Erin has collaborated with talented individuals such as Ayako Honda and Ivan Cornella Taracido. These collaborations have further enriched her research and innovation efforts.
Conclusion
Erin Keaney is a pioneering inventor whose work in Vps34 inhibition is paving the way for new therapeutic approaches. Her contributions to the field are invaluable and demonstrate the importance of innovation in addressing complex medical challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.